MetaCap

Corvus Pharmaceuticals Statistics

NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.67-0.34 (-3.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Corvus Pharmaceuticals by the numbers

Corvus Pharmaceuticals has a market capitalization of $815.7 million based on 84.35M shares outstanding. With trailing EPS of $-0.72, Corvus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 29.6% below its 200-day average.

Average daily trading volume is 1.05M shares, or about $10.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CRVS valuation vs. peer median

CRVS compared with the median of 8 peer companies
MetricCRVSPeer medianDifference
Market cap$815.69M$791.36M+3%
Avg. volume1.05M1.17M-11%

Peer median across 8 companies: PHAR, VSTM, SNDX, IRWD, MTRI, LTGO, COLL, ORIC.

Valuation

Price and trading

Previous close
10.01
Open
9.84
Day range
9.56 – 10.03
52-week range
6.39 – 26.95
52-week change
+12.84%
Beta
—
Volume
927.52K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
815.69M
Forward Pe
-8.79
Eps
-0.72
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
26.95
Week52 Low
6.39
Avg Volume
1.05M
Shares Outstanding
84.35M
Ma50
10.84
Ma200
13.73
Earnings Date
Nov 5, 2026
Pct From52w High
-64.12%
Pct From52w Low
51.33%

Related